Cellbricks logo

Cellbricks

Cellbricks envisions a future where 3D-bioprinting of human tissue and organs is a common medical practice

26 employees · est. 2016 · Berlin, Germany

VS
EDmicBio Inc. logo

EDmicBio Inc.

Investigate your drug with 3D biomimicry 3D organ-on-a-chip. We can build a better future for human

3 employees · est. 2019 · Seoul, Korea South

Cellbricks is the older company (2016 vs 2019); Cellbricks is the larger of the two.

Side-by-Side Comparison

Cellbricks EDmicBio Inc.
Founded
2016 older 2019
Headquarters
Berlin, Germany Seoul, Korea South
Employees
26 larger 3
Industry
Biotechnology, Life Sciences, Manufacturing Information Technology
Funding Stage
Series Unknown Seed
Total Funding
Not tracked yet Not tracked yet
Funding Rounds
2 1
Services
Development of Cell-based Human Tissue Therapeutics, Biofabrication of Human Tissues, AI-driven Tissue Engineering Solutions, Production of Scalable and Functional Tissues for Medical Use Development of 3D organ-on-a-chip platforms, Research on drug discovery, Solutions for disease treatment
Target Customers
Healthcare Providers, Medical Researchers, Biotechnological Companies, Patients with Tissue Dysfunction Pharmaceutical Companies, Biotechnology Firms, Healthcare Institutions, Research Laboratories
Taxonomy
3D-bioprinting, Bioprinting, Biofabrication, Synthetic Biology, Tissue Engineering, Regenerative Medicine, Tissue Therapeutics, Organ Printing, HealthTech, Recombinant Collagen, Autologous Tissue Implants, Pharmaceuticals, Lab Models, Breast Reconstruction 3D Bioprinting, Organ-on-a-chip, Tissue Engineering, Stent Development, Biodegradable Medical Devices, Bioink Technology, Drug Testing Platforms, 3D Printing Systems, Microfluidics, In-vitro Drug Testing, Patient-specific Drug Development, Organ Fabrication, Biochemical Environment Mimicry, New Drug Development, Animal Testing Replacement
Website
cellbricks.com edmicbio.com
Cellbricks logo

About Cellbricks

Cellbricks, founded in 2016, is a promising player at the intersection of Biotechnology, Life Sciences, Manufacturing, and 3D Printing. The company is headquartered in Germany, specifically in Berlin, a city renowned for its vibrant startup culture. The company’s mission is encapsulated in its slog...

EDmicBio Inc. logo

About EDmicBio Inc.

EDmicBio Inc., established in 2019 and headquartered in Korea South, is pioneering the frontier of 3D bioprinting technology. With the innovative mission to “Investigate your drug with 3D biomimicry, 3D organ-on-a-chip. We can build a better future for humans,” this startup expertly combines fields...

We will tell you when either one moves

BounceWatch watches Cellbricks and EDmicBio Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cellbricks and EDmicBio Inc. — by email.

Frequently Asked Questions

Cellbricks — Cellbricks envisions a future where 3D-bioprinting of human tissue and organs is a common medical practice. EDmicBio Inc. — Investigate your drug with 3D biomimicry 3D organ-on-a-chip. We can build a better future for human. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cellbricks and EDmicBio Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cellbricks with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cellbricks on 14 May 2026, and EDmicBio Inc. on 12 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy